P3 Health Partners Inc. has announced its financial results for the third quarter of 2026, showcasing a robust performance that has led to an increase in its full-year guidance. The company reported a total revenue of $396 million, a 15% increase compared to the same quarter last year. This growth is attributed to improved network economics and a successful approach to managing medical costs.

Dr. Aric Coffman, CEO of P3 Health Partners, expressed optimism about the company's trajectory, stating, "This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners."

The company reported an adjusted EBITDA of $21 million for the third quarter and $101 million year-to-date. Additionally, P3 raised its full-year 2026 adjusted EBITDA guidance midpoint to $100 million, reflecting a positive outlook based on year-to-date performance.

Background

P3 Health Partners Inc. operates in the health services sector, specifically focusing on population health management. The company trades on the Nasdaq under the ticker symbols PIII and PIIIW. Its recent filings include a 10-Q and an 8-K, both submitted on November 9, 2026, which detail the company's financial performance and operational updates.

What the Filing Says

According to the filing, "On November 9, 2026, P3 Health Partners Inc. announced its financial results for the three and nine months ended September 30, 2026." The filing also includes a press release that provides further details on the company's performance and future outlook.

Impact

This positive financial performance may affect various stakeholders, including investors, employees, and healthcare partners. The company's ability to raise guidance indicates a strong operational foundation, which could enhance investor confidence and attract potential partnerships in the healthcare space.

What's Next

P3 Health Partners is expected to continue its momentum into 2027, as indicated by the optimistic statements from management. The filing does not specify any immediate next steps beyond the positive outlook provided in the earnings report.